In vitro studies have demonstrated that atorvastatin downregulates T helper cells and thereby decreases inflammatory cytokines such as IL-1β, IL-6, IL-17 and IFN-γ (21), which are elevated in blepharitis and dry eye patients (8, 14). Here, IL6 is linked to Keratoconjunctivitis sicca.